Metraipolis › archive › dc_0813ef8af434

Brusatol suppresses meningioma progression via targeting HMGCR to restrict the cholesterol biosynthesis and inhibit PI3K/AKT signaling pathway — Europe PMC PMID:42453581

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42453581
DOI
10.3389/fphar.2026.1864031
License (as archived)
solo-consultazione
Archived
2026-10-31T06:38:28.608Z
SHA-256 of the archived text
46a1fe80896f49a699916af9d5453bd4c14603ed3b67c7e47f6bc16909cbabb8
Stable URL of this page
https://metraipolis.com/documento/dc_0813ef8af434

How to cite

Brusatol suppresses meningioma progression via targeting HMGCR to restrict the cholesterol biosynthesis and inhibit PI3K/AKT signaling pathway — Europe PMC PMID:42453581 — Europe PMC (en), https://europepmc.org/article/MED/42453581 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0813ef8af434 (Metraipolis archive dc_0813ef8af434, sha256 46a1fe80896f49a699916af9d5453bd4c14603ed3b67c7e47f6bc16909cbabb8)
BibTeX
@misc{dc0813ef8af434,
  title = {Brusatol suppresses meningioma progression via targeting HMGCR to restrict the cholesterol biosynthesis and inhibit PI3K/AKT signaling pathway — Europe PMC PMID:42453581},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42453581},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0813ef8af434; sha256 46a1fe80896f49a699916af9d5453bd4c14603ed3b67c7e47f6bc16909cbabb8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42453581. Agents can read the archived copy with the MCP tool read_document.